Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas

被引:120
作者
van Praag , V. M. [1 ]
Rueten-Budde, A. J. [2 ]
Ho, V [3 ]
Dijkstra, P. D. S. [1 ]
Fiocco, M. [2 ,4 ]
van de Sande, M. A. J. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Orthopaed Surg, Albinusdreef 2, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Math Inst, Rapenburg 70, NL-2311 EZ Leiden, Netherlands
[3] Netherlands Comprehens Canc Org IKNL, Dept Res, Godebaldkwartier 419, NL-3511 DT Utrecht, Netherlands
[4] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Albinusdreef 2, NL-2300 RC Leiden, Netherlands
来源
SURGICAL ONCOLOGY-OXFORD | 2018年 / 27卷 / 03期
关键词
Prognosis; Incidence; Chondrosarcoma; ATYPICAL CARTILAGINOUS TUMORS; BONE; SURVIVAL; ENCHONDROMA;
D O I
10.1016/j.suronc.2018.05.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: There are few studies detailing the incidence, patient outcomes and prognostic factors for chondrosarcomas (CS). Those that do exist have small sample sizes and/or use older datasets. The purpose of this study was to determine the incidence, overall survival (OS) and prognostic factors for OS of CS patients, as well as investigate the efficacy of curettage. Methods: We analyzed data of 2186 patients diagnosed with chondrosarcomas between '89-'13 from the Netherlands Cancer Registry. The effect of risk factors on OS was assessed with a multivariate Cox regression. Median Follow-up was determined with reversed Kaplan-Meier. OS was estimated using Kaplan-Meier method. Results: The relative incidence of CS was 2.88 per million citizens between '89-'96, 4.15 between '96-'04 and 8.78 between '05-'13. Most of the increase in incidence came from atypical cartilaginous tumours/grade I chondrosarcoma (ACT/CS I). The 3-, 5- and 10-years survival were, respectively, 96%, 93% and 88% for ACT/CS I, 82%, 74% and 62% for grade II CS and 38%, 31% and 26% for grade III CS. Prognostics factors significantly associated with OS were age, histological grade, year of diagnosis, tumour location and size. Conclusion: The incidence of CS, and especially ACT/CS I, has increased over time, which could be driven by both an ageing population and increased diagnostic imaging. With the increased number of diagnosed ACT/CS I, the number of preventative curettages of this tumour has also increased. Despite the supposed preventative character of this treatment, the incidence of high-grade CS did not decrease. (C) 2018 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:402 / 408
页数:7
相关论文
共 31 条
  • [1] Survival and prognostic factors in chondrosarcoma Results in 115 patients with long-term follow-up
    Andreou, Dimosthenis
    Ruppin, Sebastian
    Fehlberg, Sebastian
    Pink, Daniel
    Werner, Mathias
    Tunn, Per-Ulf
    [J]. ACTA ORTHOPAEDICA, 2011, 82 (06) : 749 - 755
  • [2] [Anonymous], 2000, International classification of diseases for Oncology
  • [3] [Anonymous], 2011, TRENDS STAND ZAK DIA
  • [4] The contrasting age-incidence patterns of bone tumours in teenagers and young adults: Implications for aetiology
    Arora, Ramandeep S.
    Alston, Robert D.
    Eden, Tim O. B.
    Geraci, Marco
    Birch, Jillian M.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (07) : 1678 - 1685
  • [5] Bertoni F., 2002, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
  • [6] Björnsson J, 1998, CANCER, V83, P2105
  • [7] Do pathological fractures influence survival and local recurrence rate in bony sarcomas?
    Bramer, J. A. M.
    Abudu, A. A.
    Grimer, R. J.
    Carter, S. R.
    Tillman, R. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (13) : 1944 - 1951
  • [8] How safe is curettage of low-grade cartilaginous neoplasms diagnosed by imaging with or without pre-operative needle biopsy?
    Brown, M. T.
    Gikas, P. D.
    Bhamra, J. S.
    Skinner, J. A.
    Aston, W. J. S.
    Pollock, R. C.
    Saifuddin, A.
    Briggs, T. W. R.
    [J]. BONE & JOINT JOURNAL, 2014, 96B (08) : 1098 - 1105
  • [9] Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Casali, Paolo G.
    Blay, Jean-Yves
    Bertuzzi, Alexia
    Bielack, Stefan
    Bjerkehagen, Bodil
    Bonvalot, Sylvie
    Boukovinas, Ioannis
    Bruzzi, Paolo
    Dei Tos, Angelo Paolo
    Dileo, Palma
    Eriksson, Mikael
    Fedenko, Alexander
    Ferrari, Andrea
    Ferrari, Stefano
    Gelderblom, Hans
    Grimer, Robert
    Gronchi, Alessandro
    Haas, Rick
    Hall, Kirsten Sundby
    Hohenberger, Peter
    Issels, Rolf
    Joensuu, Heikki
    Judson, Ian
    Le Cesne, Axel
    Litiere, Saskia
    Martin-Broto, Javier
    Merimsky, Ofer
    Montemurro, Michael
    Morosi, Carlo
    Picci, Piero
    Ray-Coquard, Isabelle
    Reichardt, Peter
    Rutkowski, Piotr
    Schlemmer, Marcus
    Stacchiotti, Silvia
    Torri, Valter
    Trama, Annalisa
    Van Coevorden, Frits
    Van der Graaf, Winette
    Vanel, Daniel
    Wardelmann, Eva
    [J]. ANNALS OF ONCOLOGY, 2014, 25 : 113 - 123
  • [10] Is intralesional resection suitable for central grade 1 chondrosarcoma: A systematic review and updated meta-analysis
    Chen, X.
    Yu, L. J.
    Peng, H. M.
    Jiang, C.
    Ye, C. H.
    Zhu, S. B.
    Qian, W. W.
    [J]. EJSO, 2017, 43 (09): : 1718 - 1726